BERKSHIRE HATHAWAY INC (BRK-B) vs ELI LILLY & Co(LLY)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | BRK-B | LLY |
|---|---|---|
| Sector | Financials | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $371.44B | $65.18B |
| Revenue growth (YoY) | ▲ 0.0% | ▲ 44.7% |
| Net income | $67.26B | $20.64B |
| Gross margin | — | — |
| Diluted EPS | — | $22.95 |
| Insider net (6 mo) | −787.6K sh · 4 sells · 2 buys | −31.0K sh · 5 sells · 0 buys |
| Institutional owners | 50 | 51 |
| Institutional value held | $215.24B | $533.23B |
| Next earnings (est.) | Around Nov 2, 2026 | Around Oct 29, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About BERKSHIRE HATHAWAY INC (BRK-B)
Berkshire Hathaway Inc., a Delaware-domiciled holding company headquartered in Omaha, Nebraska, operates a diverse portfolio of businesses managed under a highly decentralized structure, with its Chief Executive Officer responsible for major capital allocation
About ELI LILLY & Co (LLY)
Eli Lilly and Company, incorporated in Indiana in 1901 and tracing its roots to a drug manufacturing business founded in 1876, operates as a single-segment human pharmaceutical company focused on discovering, developing, manufacturing, and marketing innovative
Source: SEC EDGAR.